Table 3 Analytical values evolution
Range | IQR | ||
|---|---|---|---|
Patient (n) | 24 | ||
Baseline analysis | |||
Br | 0.9 | (0.3–4.1) | 0.5–1 |
Alb | 4,01 | (2.5–4.8) | 3.7–4.5 |
ALT | 37.9 | (16–82) | 25–49 |
AST | 38.3 | (20–50) | 31–47 |
3 m analysis | |||
Br | 0.97 | (0.3–3.6) | 0.6–1.25 |
Alb | 3.9 | (2.8–4.4) | 3.8–4.2 |
ALT | 34.8 | (12–72) | 24.5–42.5 |
AST | 43.3 | (18–80) | 29–57 |
6 m analysis | |||
Br | 1.03 | (0.4–2.5) | 0.7–1.1 |
Alb | 3.9 | (3.2–4.6) | 3.6–4.4 |
ALT | 44.3 | (18–149) | 30–45 |
AST | 60.3 | (20–214) | 40–57 |